Evidence map›Paper›PMID 27463518›Full record

ArticlePLoS neglected tropical diseases2016

Insights into an Optimization of Plasmodium vivax Sal-1 In Vitro Culture: The Aotus Primate Model.

Kathryn Shaw-Saliba, Richard Thomson-Luque, Nicanor Obaldía, Marlon Nuñez, Sahir Dutary, Caeul Lim, Samantha Barnes, Clemens H M Kocken, Manoj T Duraisingh, John H Adams and 1 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Low-volumeMicrobial genomics · 2025
    Article
  3. The human malaria-Antimicrobial agents and chemotherapy · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Home Sweet Home:Frontiers in cellular and infection microbiology · 2021
    Review
  8. Article
  9. Human Plasmodium vivax mosquito experimental transmission.The Journal of clinical investigation · 2020
    Article
  10. A Way Forward for Culturing Plasmodium vivax.Trends in parasitology · 2020
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kathryn Shaw-SalibaDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Richard Thomson-LuqueCenter for Global Health & Infectious Diseases Research, Department of Global Health, College of Public Health, University of South Florida, Tampa, Florida, United States of America.
Nicanor ObaldíaCenter for the Evaluation of Antimalarial Drugs and Vaccines, Tropical Medicine Research / Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá, Panamá
Marlon NuñezCenter for the Evaluation of Antimalarial Drugs and Vaccines, Tropical Medicine Research / Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá, Panamá
Sahir DutaryCenter for the Evaluation of Antimalarial Drugs and Vaccines, Tropical Medicine Research / Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá, Panamá
Caeul LimDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Samantha BarnesCenter for Global Health & Infectious Diseases Research, Department of Global Health, College of Public Health, University of South Florida, Tampa, Florida, United States of America.
Clemens H M KockenBiomedical Primate Research Centre, Rijswijk, The Netherlands.
Manoj T DuraisinghDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
John H AdamsCenter for Global Health & Infectious Diseases Research, Department of Global Health, College of Public Health, University of South Florida, Tampa, Florida, United States of America.
Erica M PasiniBiomedical Primate Research Centre, Rijswijk, The Netherlands.

Funding

Immunological characterization of the P. vivax DBPR01AI064478 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI ADAMS, JOHN H · 2006 to 2023
$9.6M
6 · The paper itself

Abstract

Malaria is one of the most significant tropical diseases, and of the Plasmodium species that cause human malaria, P. vivax is the most geographically widespread. However, P. vivax remains a relatively neglected human parasite since research is typically limited to laboratories with direct access to parasite isolates from endemic field settings or from non-human primate models. This restricted research capacity is in large part due to the lack of a continuous P. vivax in vitro culture system, which has hampered the ability for experimental research needed to gain biological knowledge and develop new therapies. Consequently, efforts to establish a long-term P. vivax culture system are confounded by our poor knowledge of the preferred host cell and essential nutrients needed for in vitro propagation. Reliance on very heterogeneous P. vivax field isolates makes it difficult to benchmark parasite characteristics and further complicates development of a robust and reliable culture method. In an effort to eliminate parasite variability as a complication, we used a well-defined Aotus-adapted P. vivax Sal-1 strain to empirically evaluate different short-term in vitro culture conditions and compare them with previous reported attempts at P. vivax in vitro culture Most importantly, we suggest that reticulocyte enrichment methods affect invasion efficiency and we identify stabilized forms of nutrients that appear beneficial for parasite growth, indicating that P. vivax may be extremely sensitive to waste products. Leuko-depletion methods did not significantly affect parasite development. Formatting changes such as shaking and static cultures did not seem to have a major impact while; in contrast, the starting haematocrit affected both parasite invasion and growth. These results support the continued use of Aotus-adapted Sal-1 for development of P. vivax laboratory methods; however, further experiments are needed to optimize culture conditions to support long-term parasite development.

Indexed as

Plasmodium vivaxAnimalsAotidaeCell Culture TechniquesCulture MediaFemaleMalaria, VivaxReticulocytesCulture Media

Identifiers

PMID27463518
PMCPMC4963040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.